AKT1 and cancer: Cancer cells with functional aberrations, such as overexpression of HER family members or increased cell adhesion potential, are probably more capable than noncancerous cells of activating Akt as a defensive mechanism against external detrimental stimuli, which justifies a novel approach of targeting the PI3-K/Akt for chemosensitization or radiosensitization.